Pro/con debate: Lung allocation should be based on medical urgency and transplant survival and not on waiting time

Chest

Volumn 128, Issue 1, 2005, Pages 407-415

  Egan, Thomas M ^b   Kotloff, Robert M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Lung transplantation; Organ allocation; Resource allocation

Indexed keywords

EMERGENCY TREATMENT; HOSPITAL ADMISSION; HUMAN; LUNG PARENCHYMA; LUNG TRANSPLANTATION; PRIORITY JOURNAL; RESOURCE ALLOCATION; REVIEW; SCORING SYSTEM; SURVIVAL;

EID: 22244471373     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.1.407     Document Type: Article

References (41)

1. U.S. Organ Procurement and Transplantation Network and The Scientific Registry of Transplant Recipients. 2003 Annual Report of the U.S. Organ Procurement and Transplantation Network and The Scientific Registry of Transplant Recipients. Rockville, MD/Richmond, VA: U.S. Department of Health and Human Services/Health Resources and Services Administration (HHS/HRSA)/United Network for Organ Sharing (UNOS), 2004
2. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation (ISHLT). International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med 1998; 158:335-339
3. Department of Health and Human Services. Organ Procurement and Transplantation Network: final rule; 42 CFR-Part 121. Federal Register, October 20, 1999; 56649-56661
4. Committee on Organ Procurement and Transplantation Policy, Division of Health Sciences Policy, Institute of Medicine. Organ procurement and transplantation: assessing current policies and the potential impact of the DHHS final rule. Washington, DC: National Academy Press, 1999
5. Egan T. Ethical issues in thoracic organ distribution for transplant. Am J Transplant 2003; 3:366-372
6. Hosenpud JD, Bennett LE, Keck BM, et al. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351:24-27
7. Hadorn D. Setting health care priorities in Oregon: cost effectiveness meets the rule of rescue. JAMA 1991; 265:2218-2225
8. Jonsen A. Bentham in a box: technology assessment and health care allocation. Law Med Health Care 1986; 14:172-174
9. United Network for Organ Sharing. UNOS Update. Richmond, VA: United Network for Organ Sharing (UNOS), 1994
10. Childress J. The gift of life: ethical issues in organ transplantation; ACS Regents Committee on Ethics-1995 Ethics and Philosophy Lecture. Available at: http://www.facs.org/education/ethics/childresslect.html. Accessed August 20, 2004
11. Egan TM, Bennett LE, Garrity ER, et al. Are there predictors of death at the time of listing for lung transplant [abstract]? J Heart Lung Transplant 2002; 21:154
12. Egan T, McCullough K, Murray S, et al. Risk factors for death after lung transplant in the U.S. [abstract]. J Heart Lung Transplant 2003; 22:8146-8147
13. Organ Procurement and Transplantation Network. Policy 3.7: Allocation of Thoracic Organs (revised June 25, 2004). Available at: http://www.optn.org/ PoliciesandBylaws/policies/pdfs/policy_9.pdf Accessed December 29, 2004
14. Liou TG, Adler FR, Fitzsimmons SC, et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001; 153:345-352
15. Kerem E, Reisman J, Corey M, et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992; 326:1187-1191
16. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991; 115:343-349
17. McMullen LE. Equitable allocation of human organs: an examination of the new federal regulation. J Leg Med 1999; 20:405-424
18. Egan TM, Lambert CJ Jr, Reddick RL, et al. A strategy to increase the donor pool: the use of cadaver lungs for transplantation. Ann Thorac Surg 1991; 52:1113-1121
19. Egan T. Non-heart beating donors in thoracic transplantation. J Heart Lung Transplant 2004; 23:3-10
20. Steen S, Sjoberg T, Pierre L, et al. Transplantation of lungs from a non-heart beating donor. Lancet 2001; 357:825-829
21. Varela A. Are out hospital non heart beating donors (NHBD) better than brain death lung donors [abstract]? J Heart Lung Transplant 2004; 23:887
22. Hosenpud JD, Bennett LE, Keck BM, et al. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351:24-27
23. United Network for Organ Sharing. Policy 3.7: organ distribution: allocation of thoracic organs. Available at: http://www.unos.org/ policiesandbylaws/policies.asp?resources=true. Accessed June 20, 2005
24. Braitman LE, Davidoff F. Predicting clinical states in individual patients. Ann Intern Med 1996; 125:406-412
25. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med 1999; 130:515-524
26. McGinn TG, Guyatt GH, Wyer PC, et al. Users' guides to the medical literature: XXII. How to use articles about clinical decision rules: Evidence-Based Medicine Working Group. JAMA 2000; 284:79-84
27. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871
28. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470
29. Merion RM, Wolfe RA, Dykstra DM, et al. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003; 9:12-18
30. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124:91-96
31. Kerem E, Reisman J, Corey M, et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992; 326:1187-1191
32. Maurer JR, Frost AE, Estenne M, et al. International guidelines for the selection of lung transplant candidates. J Heart Lung Transplant 1998; 17:703-709
33. 1 may adversely affect overall survival. Chest 1999; 115:782-787
34. Milla CE, Warwick WJ. Risk of death in cystic fibrosis patients with severely compromised lung function. Chest 1998; 113:1230-1234
35. Liou TG, Adler FR, Fitzsimmons SC, et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001; 153:345-352
36. Mayer-Hamblett N, Rosenfeld M, Emerson J, et al. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 2002; 166:1550-1555
37. Vizza CD, Yusen RD, Lynch JP, et al. Outcome of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2000; 162:819-825
38. De Meester J, Smits JM, Persijn GG, et al. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001; 20:518-524
39. Ouwens JP, Groen H, TenVergert EM, et al. Simulated waiting list prioritization for equitable allocation of donor lungs. J Heart Lung Transplant 2002; 21:797-803
40. Hopkins WE, Ochoa LL, Richardson GW, et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 1996; 15:100-105
41. Trulock EP, Edwards LB, Taylor DO, et al. The registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 2004; 23:804-815